https://www.selleckchem.com/pr....oducts/ac-fltd-cmk.h
The online version contains supplementary material available at 10.1007/s10680-021-09597-x.This study aimed to evaluate the efficacy and safety of "highly exposed Chinese herbal medicine" combined with apatinib as maintenance treatment following first-line or second-line chemotherapy in patients with ES-SCLC. A total of 23 patients with ES-SCLC were included in this single-arm prospective study (ChiCTR2100045255). "Highly exposed Chinese herbal medicine" combined with apatinib was administered each day after the chemotherapy for mai
Mi piace
Commento
Condividi
